Conclusion: An Antioxidant from the Inside and Out When you see glutathione upregulation, MMP inhibition, increased collagen synthesis, and DNA repair all attributed to the same substance, you should realize that we're talking about mechanisms for optimizing health and wellness that are as fundamental and far-reaching as it gets

Abbreviations AhR: Aryl hydrocarbon receptor AMPK: AMP-activated protein kinase APC: Antigenpresenting cell CAR-T: Chimeric antigen receptor T cell CCA: Cholangiocarcinoma CRC: Colorectal cancer CTL: Cytotoxic T lymphocyte CXCR: C-X-C chemokine receptor DCs: Dendritic cells DCA: Deoxycholic acid FFAR2: Free fatty acid receptor 2 FMT: Fecal microbiota transplantation GPCR: G protein-coupled receptors HCC: Hepatocellular carcinoma ICB: Immune checkpoint blockade ICI: Immune checkpoint inhibitor IDO: Indoleamine 23dioxygenase ILA: Indole3lactic acid iNKT: Invariant NKT IPA: Indole3propionic acid IPyA: Indole3pyruvic acid LCA: Lithocholic acid LPS: Lipopolysaccharide MAMPs: Microbeassociated molecular patterns MDSCs: Myeloidderived suppressor cells NK: Natural killer cell NKT: Natural killer T cell NOD: Nucleotidebinding oligomerization domain NSCLC: Nonsmall cell lung cancer PCa: Prostate cancer PDAC: Pancreatic ductal adenocarcinoma PPAR: Peroxisome proliferatoractivated receptor PRR: Pattern recognition receptor ROS: Reactive oxygen species SBAs: Secondary bile acids SCFAs: Shortchain fatty acids STAT3: Signal transducer and activator of transcription 3 TAMs: Tumorassociated macrophages TCR: T-cell receptor TLCA: Taurolithocholic acid TLR4: Tolllike receptor 4 TMAO: Trimethylamine Noxide TME: Tumor microenvironment Tregs: Regulatory T cells TNBC: Triplenegative breast cancer UDCA: Ursodeoxycholic acid 3-IAA: Indole3acetic acid References Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al

Energy Crisis : Injured brain cells use up extra ATP (the cells energy source) as they try to repair themselves and restore balance, leading to whats called the metabolic cascade
Krajnc N, Itariu B, Macher S et al (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension